What's Next for Chronic Hives? New Targets Expand the Treatment Landscape.

(MedPage Today) -- New and emerging therapies for chronic spontaneous urticaria (CSU) were a major focus at the American Academy of Dermatology (AAD) meeting, with advances spanning interleukin (IL)-4 receptor blockade, Bruton's tyrosine kinase...